Terms: = Thyroid cancer AND EBF1, COE1, 1879, ENSG00000164330, Q9UH73, OLF1, O/E-1, EBF AND Diagnosis
11 results:
1. Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer.
Tsirona S; Vlassopoulou V; Tzanela M; Rondogianni P; Ioannidis G; Vassilopoulos C; Botoula E; Trivizas P; Datseris I; Tsagarakis S
Clin Endocrinol (Oxf); 2014 Mar; 80(3):459-63. PubMed ID: 23895145
[TBL] [Abstract] [Full Text] [Related]
2. Ectopic bone formation and extramedullary hematopoiesis in the thyroid gland: report of a case and literature review.
Akbulut S; Yavuz R; Akansu B; Sogutcu N; Arikanoglu Z; Basbug M
Int Surg; 2011; 96(3):260-5. PubMed ID: 22216706
[TBL] [Abstract] [Full Text] [Related]
3. Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma.
Lewinshtein D; Gulati R; Nelson PS; Porter CR
BJU Int; 2012 Mar; 109(5):706-12. PubMed ID: 21883828
[TBL] [Abstract] [Full Text] [Related]
4. thyroid surgery in octogenarians is associated with higher complication rates.
Mekel M; Stephen AE; Gaz RD; Perry ZH; Hodin RA; Parangi S
Surgery; 2009 Nov; 146(5):913-21. PubMed ID: 19744461
[TBL] [Abstract] [Full Text] [Related]
5. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
[TBL] [Abstract] [Full Text] [Related]
6. thyroid cancer and multiple primary tumors in the SEER cancer registries.
Ronckers CM; McCarron P; Ron E
Int J Cancer; 2005 Nov; 117(2):281-8. PubMed ID: 15880372
[TBL] [Abstract] [Full Text] [Related]
7. Study of anti-striational and anti-thyroid antibodies in patients with myasthenia gravis.
Cojocaru IM; Cojocaru M; Muşuroi C
Rom J Intern Med; 2000-2001; 38-39():111-20. PubMed ID: 15529579
[TBL] [Abstract] [Full Text] [Related]
8. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.
Dores GM; Metayer C; Curtis RE; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; van Leeuwen FE; Holowaty EJ; Andersson M; Wiklund T; Joensuu T; van't Veer MB; Stovall M; Gospodarowicz M; Travis LB
J Clin Oncol; 2002 Aug; 20(16):3484-94. PubMed ID: 12177110
[TBL] [Abstract] [Full Text] [Related]
9. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
[TBL] [Abstract] [Full Text] [Related]
10. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.
Henry-Amar M
Ann Oncol; 1992 Sep; 3 Suppl 4():117-28. PubMed ID: 1450072
[TBL] [Abstract] [Full Text] [Related]
11. Second primary cancers following colon and rectal cancer in Osaka, Japan.
Tanaka H; Hiyama T; Hanai A; Fujimoto I
Jpn J Cancer Res; 1991 Dec; 82(12):1356-65. PubMed ID: 1778758
[TBL] [Abstract] [Full Text] [Related]
